TOCQUEVILLE ASSET MANAGEMENT L.P. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$455,000
+45.4%
19,591
-0.4%
0.01%
+50.0%
Q1 2018$313,000
-31.8%
19,666
-11.0%
0.00%
-20.0%
Q4 2017$459,000
-68.6%
22,091
-78.3%
0.01%
-70.6%
Q3 2017$1,460,000
+285.2%
101,914
+365.1%
0.02%
+240.0%
Q2 2017$379,000
+62.7%
21,914
+3.8%
0.01%
+66.7%
Q1 2017$233,000
-64.8%
21,114
-53.7%
0.00%
-62.5%
Q4 2016$662,000
-52.4%
45,614
-19.4%
0.01%
-52.9%
Q3 2016$1,390,000
-33.0%
56,614
-45.1%
0.02%
+30.8%
Q2 2016$2,076,000
+95.3%
103,038
+154.9%
0.01%
-7.1%
Q1 2016$1,063,000
-65.4%
40,424
+33.8%
0.01%
-66.7%
Q4 2015$3,070,000
-80.3%
30,205
-65.4%
0.04%
-79.8%
Q3 2015$15,557,000
-24.8%
87,211
-6.3%
0.21%
-14.8%
Q2 2015$20,682,000
+5.2%
93,101
-5.9%
0.24%
+5.6%
Q1 2015$19,658,000
+7.3%
98,974
-22.7%
0.23%
+17.3%
Q4 2014$18,314,000
+7.4%
127,969
-1.5%
0.20%
+4.2%
Q3 2014$17,049,000
-0.1%
129,946
-4.0%
0.19%
+13.9%
Q2 2014$17,063,000
-16.0%
135,291
-12.2%
0.17%
-37.8%
Q1 2014$20,319,000
+7.5%
154,128
-4.2%
0.27%
+5.1%
Q4 2013$18,894,000
+13.9%
160,938
+1.3%
0.25%
+22.7%
Q3 2013$16,583,000
+9.4%
158,945
-9.7%
0.21%
+1.0%
Q2 2013$15,158,000176,0950.20%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2016
NameSharesValueWeighting ↓
Chou Associates Management 1,648,992$38,323,00014.52%
Paulson & Co. 20,839,035$484,299,0009.89%
MILLER VALUE PARTNERS, LLC 4,999,064$116,178,0004.34%
GoldenTree Asset Management 1,140,205$26,498,0004.21%
Pomelo Capital LLC 1,760,000$40,902,0004.00%
Bruce & Co., Inc. 860,000$19,986,0003.98%
ValueAct Holdings 18,033,149$419,090,0003.79%
Stanley Capital Management, LLC 318,400$7,400,0003.25%
Kazazian Asset Management, LLC 134,784$3,132,0002.87%
Phoenix Investment Adviser LLC 58,400$1,357,0002.48%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders